P186D

PART B: Clinical Review of Newer Longer-acting Insulins in Persons with Diabetes

Claim your 0.25h CE/CME Credit Here
Name*

First Name Last Name
Email*
example@example.com
What best describes your title?*

MD/DORN/NPPAPharmD/RPhRespiratory TherapistNon-Clinician Research CoordinatorOther
If MD/DO

cardiologist (interventional)cardiologist (heart failure)cardiologist (lipid/vascular)cardiologist (general)endocrinologistnephrologistemergency medicine specialistcritical care specialistpulmonologistprimary care providerindustryOther
If RN/NP

NPPICUcath labwardclinicacademicindustryOther
If PharmD

hospital/health system-basedcommunityacademicindustryOther
If PharmD, DOB

MonthDay Year
Date
If PharmD, NABP ID#
Where are you based?

EU/GBCanadaUSALatin AmericaAustralia/NZAsia
How did you FIRST hear about our tweetorials?

found it on Twitter searching in subject areafound it on twitter searching for CE/CMEfound it on Twitter by following individual influencerfound it on Twitter by following institutional influencerfrom LinkedIn
How many years have you been in practice?
How many patients do you typically see each month?
1. What is the minimum number of hours between daily doses of insulin degludec?*

6 hours8 hours12 hours24 hours
2. Did you follow the entire tweetorial?*

YesNo
3. Did you find this to be an effective learning tool?*

YesNo
4. Will you refer colleagues to similar programs from @cardiomet_CE?*

YesNo
MonthDay Year
Date
Course Title
Should be Empty: